|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Uhrastructural pathology' of rat lung injury induced by ischemic acute kidney injury显示文摘 | Zang DY Shao YZ Li XM | 2013 | Uhrastruct Pathol2013，37，6： | 1 |
| 2 | Expression of tumor necrosis factor-related apoptosis-inducing ligand,Apo2L,and its receptors in myelodysplastic syndrome:effects on in vitro hemopoiesis显示文摘 | Zang DY Goodwin RG Loken MR | 2001 | {H}Blood2001，，10： | 1 |
| 3 | Phase II study with oxalipla-tin and S-1 for patients with metastatic colorectal cancer显示文摘 | Zang DY Lee BH Park HC | 2009 | AnnOncol2009，20，： | 1 |
| 4 | Phase Ⅱ study with oxaliplatin and S - 1 for patients with metastatic colorectal cancer显示文摘 | Zang DY Lee BH Park HC | 2010 | Ann On- col2010，21，5： | 1 |
| 5 | Phase I/II trial with Docetaxeland S - 1 for patients with advanced or recurrent gastric cancer withconsideration to age 显示文摘 | Zang DY Yang DH Lee HW | 2009 | Cancer Chemother Pharmacol2009，63，3： | 1 |
| 6 | Phase II study with oxaliplatinand S - 1 for patients with metastatic colorectal cancer 显示文摘 | Zang DY Lee BH Park HC | 2009 | Ann0ncol2009，20，5： | 1 |
| 7 | Phase I /II trial with Docetaxeland S-1 for patients with advanced or recurrent gastric cancer with consideration to age 显示文摘 | Zang DY Yang DH Lee HW | 2009 | Cancer Chemother Pharmacol2009，63，3： | 1 |
| 8 | Dose - finding study of docetax-el oxaliplatin,and S - 1 for patients with advanced gastric cancer显示文摘 | Zang DY Yang DH Kim MJ | 2009 | Cancer Chemother Pharmacol2009，63，： | 1 |
| 9 | Differential susceptibilityof gastrin cancer nells to TRAIL-induoed apoptosis显示文摘 | SONG NM JUN S ZANG DY | 2013 | OncolRep2013，29，3： | 1 |
| 10 | Phase 1I study with oxaliplatin and S-1 for patients with metastatic colorectal cancer显示文摘 | Zang DY Lee BH Park HC | 2009 | Ann Oncol2009，20，5： | 1 |
| 11 | Phase Ⅱ study with oxaliplatin and S-1 for patients with metastatic colorectal cancer显示文摘 | Zang DY Lee BH Park HC | 2009 | Ann Oneol2009，20，5： | 1 |
| 12 | Expression of tumor necrosis factor-related apoptosis-inducing ligand,Apo2L,and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis显示文摘 | Zang DY Goodwin RG Loken MR | 2001 | Blood2001，98，10： | 1 |
| 13 | Phase Ⅱ study with oxaliplatin and S-I for patients with metastatic colorectal cancer显示文摘 | Zang DY Lee BH Park HC | 2009 | AnnOncol2009，20，： | 1 |
| 14 | Phase Ⅰ/Ⅱ tri- al with Docetaxel and S-I for patients with ad- vanced or recurrent gastric cancer with considera- tion to age 显示文摘 | Zang DY Yang DH Lee HW | 2009 | Cancer Chemother Pharmacol2009，63，3： | 1 |
| 15 | Phase H trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small-cell lung cancer显示文摘 | Zang DY Lee KH Lee JS Lee JH Kim WK Kim SH | 1999 | Am J Clin Oncol1999，22，5： | 1 |
| 16 | Phase II study of docetaxel,oxaliplatin,and S-1therapy in patients with metastatic gastric cancer显示文摘 | Kim HS Ryu MH Zang DY | 2016 | Gastric Cancer2016，19，2： | 1 |
| 17 | Dose-finding study of docetaxel,oxaliplatin,and S-1 for patients with advanced gastric cancer显示文摘 | Zang DY Yang D-H Kim MJ | 2009 | Cancer Chemother Pharmacol2009，64，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员